These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 17656053)
1. A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe. Aburub A; Risley DS; Mishra D Int J Pharm; 2008 Jan; 347(1-2):16-22. PubMed ID: 17656053 [TBL] [Abstract][Full Text] [Related]
2. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. Lehto P; Kortejärvi H; Liimatainen A; Ojala K; Kangas H; Hirvonen J; Tanninen VP; Peltonen L Eur J Pharm Biopharm; 2011 Aug; 78(3):531-8. PubMed ID: 21329757 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Enzymes and Sodium Lauryl Sulfate on the Surface Tension of Dissolution Media: Toward Understanding the Solubility and Dissolution of Carvedilol. Hamed R; Alnadi SH; Awadallah A AAPS PharmSciTech; 2020 May; 21(5):146. PubMed ID: 32435989 [TBL] [Abstract][Full Text] [Related]
4. Weak bases and formation of a less soluble lauryl sulfate salt/complex in sodium lauryl sulfate (SLS) containing media. Bhattachar SN; Risley DS; Werawatganone P; Aburub A Int J Pharm; 2011 Jun; 412(1-2):95-8. PubMed ID: 21527324 [TBL] [Abstract][Full Text] [Related]
5. Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. Crison JR; Weiner ND; Amidon GL J Pharm Sci; 1997 Mar; 86(3):384-8. PubMed ID: 9050810 [TBL] [Abstract][Full Text] [Related]
6. Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling. Bahr MN; Modi D; Patel S; Campbell G; Stockdale G J Pharm Pharm Sci; 2019; 22(1):221-246. PubMed ID: 31219781 [TBL] [Abstract][Full Text] [Related]
7. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation. Miller JM; Beig A; Krieg BJ; Carr RA; Borchardt TB; Amidon GE; Amidon GL; Dahan A Mol Pharm; 2011 Oct; 8(5):1848-56. PubMed ID: 21800883 [TBL] [Abstract][Full Text] [Related]
8. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum. Mitra A; Fadda HM Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699 [TBL] [Abstract][Full Text] [Related]
9. Mechanism for the Reduced Dissolution of Ritonavir Tablets by Sodium Lauryl Sulfate. Guo Y; Wang C; Dun J; Du L; Hawley M; Sun CC J Pharm Sci; 2019 Jan; 108(1):516-524. PubMed ID: 30389564 [TBL] [Abstract][Full Text] [Related]
10. Estimation of intragastric solubility of drugs: in what medium? Vertzoni M; Pastelli E; Psachoulias D; Kalantzi L; Reppas C Pharm Res; 2007 May; 24(5):909-17. PubMed ID: 17372688 [TBL] [Abstract][Full Text] [Related]
11. Co-solubilization of poorly soluble drugs by micellization and complexation. Rao VM; Nerurkar M; Pinnamaneni S; Rinaldi F; Raghavan K Int J Pharm; 2006 Aug; 319(1-2):98-106. PubMed ID: 16765542 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of sodium lauryl sulfate source variability on solid oral dosage form development. Qiang D; Gunn JA; Schultz L; Li ZJ Drug Dev Ind Pharm; 2010 Dec; 36(12):1486-96. PubMed ID: 20545515 [TBL] [Abstract][Full Text] [Related]
13. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant. Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177 [TBL] [Abstract][Full Text] [Related]
14. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3. Fuchs A; Leigh M; Kloefer B; Dressman JB Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292 [TBL] [Abstract][Full Text] [Related]
15. Rhodamine-123: a p-glycoprotein marker complex with sodium lauryl sulfate. Al-Mohizea AM; Al-Jenoobi FI; Alam MA Pak J Pharm Sci; 2015 Mar; 28(2):617-22. PubMed ID: 25730814 [TBL] [Abstract][Full Text] [Related]
16. Effects of surfactant and electrolyte concentrations on bubble formation and stabilization. Xu Q; Nakajima M; Ichikawa S; Nakamura N; Roy P; Okadome H; Shiina T J Colloid Interface Sci; 2009 Apr; 332(1):208-14. PubMed ID: 19144348 [TBL] [Abstract][Full Text] [Related]
17. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells. Zhao F; Malayev V; Rao V; Hussain M Pharm Res; 2004 Jan; 21(1):144-8. PubMed ID: 14984269 [TBL] [Abstract][Full Text] [Related]
18. Factors effecting drug release from inert matrices. Part 1: effects of surfactants on the release of quinine sulfate. Choulis NH; Papadopoulos H Pharmazie; 1975 Apr; 30(4):233-6. PubMed ID: 239411 [TBL] [Abstract][Full Text] [Related]
19. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. Park SH; Choi HK Int J Pharm; 2006 Sep; 321(1-2):35-41. PubMed ID: 16797892 [TBL] [Abstract][Full Text] [Related]
20. Interfacial and bulk behavior of sodium dodecyl sulfate in isopropanol-water and in isopropanol-poly(vinylpyrrolidone)-water media. Dan A; Chakraborty I; Ghosh S; Moulik SP Langmuir; 2007 Jul; 23(14):7531-8. PubMed ID: 17547430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]